302 related articles for article (PubMed ID: 23501043)
1. A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients.
Naimi RM; Madsen KB; Askov-Hansen C; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB
Regul Pept; 2013 Jun; 184():47-53. PubMed ID: 23501043
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
Madsen KB; Askov-Hansen C; Naimi RM; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB
Regul Pept; 2013 Jun; 184():30-9. PubMed ID: 23511332
[TBL] [Abstract][Full Text] [Related]
3. The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients.
Bremholm L; Hornum M; Andersen UB; Hartmann B; Holst JJ; Jeppesen PB
Regul Pept; 2011 Jun; 168(1-3):32-8. PubMed ID: 21421014
[TBL] [Abstract][Full Text] [Related]
4. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
[TBL] [Abstract][Full Text] [Related]
5. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
[TBL] [Abstract][Full Text] [Related]
6. Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome.
Gottschalck IB; Jeppesen PB; Hartmann B; Holst JJ; Henriksen DB
Scand J Gastroenterol; 2008; 43(11):1304-10. PubMed ID: 18609184
[TBL] [Abstract][Full Text] [Related]
7. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
Iturrino J; Camilleri M; Acosta A; O'Neill J; Burton D; Edakkanambeth Varayil J; Carlson PJ; Zinsmeister AR; Hurt R
JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1089-1095. PubMed ID: 26223941
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
9. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.
Jeppesen PB; Hartmann B; Thulesen J; Graff J; Lohmann J; Hansen BS; Tofteng F; Poulsen SS; Madsen JL; Holst JJ; Mortensen PB
Gastroenterology; 2001 Mar; 120(4):806-15. PubMed ID: 11231933
[TBL] [Abstract][Full Text] [Related]
11. Role of glucagon-like peptide-2 deficiency in neonatal short-bowel syndrome using neonatal piglets.
Hua Z; Turner JM; Sigalet DL; Wizzard PR; Nation PN; Mager DR; Ball RO; Pencharz PB; Wales PW
Pediatr Res; 2013 Jun; 73(6):742-9. PubMed ID: 23481550
[TBL] [Abstract][Full Text] [Related]
12. Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate.
Holst JJ; Hartmann B; Gottschalck IB; Jeppesen PB; Miholic J; Henriksen DB
Scand J Gastroenterol; 2007 Jul; 42(7):814-20. PubMed ID: 17558904
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.
Jeppesen PB; Hartmann B; Thulesen J; Hansen BS; Holst JJ; Poulsen SS; Mortensen PB
Gut; 2000 Sep; 47(3):370-6. PubMed ID: 10940274
[TBL] [Abstract][Full Text] [Related]
14. GLP-2 and mesenteric blood flow.
Hansen LB
Dan Med J; 2013 May; 60(5):B4634. PubMed ID: 23673268
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; Qvist N; Burrin DG; Jeppesen PB; Holst JJ; Sangild PT
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G277-85. PubMed ID: 23764891
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
Sueyoshi R; Woods Ignatoski KM; Okawada M; Hartmann B; Holst J; Teitelbaum DH
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(4):G410-9. PubMed ID: 24970775
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome.
Kunkel D; Basseri B; Low K; Lezcano S; Soffer EE; Conklin JL; Mathur R; Pimentel M
Neurogastroenterol Motil; 2011 Aug; 23(8):739-e328. PubMed ID: 21557790
[TBL] [Abstract][Full Text] [Related]
18. Exogenous glucagon-like peptide-2 improves outcomes of intestinal adaptation in a distal-intestinal resection neonatal piglet model of short bowel syndrome.
Suri M; Turner JM; Sigalet DL; Wizzard PR; Nation PN; Ball RO; Pencharz PB; Brubaker PL; Wales PW
Pediatr Res; 2014 Oct; 76(4):370-7. PubMed ID: 24995913
[TBL] [Abstract][Full Text] [Related]
19. Modern treatment of short bowel syndrome.
Jeppesen PB
Curr Opin Clin Nutr Metab Care; 2013 Sep; 16(5):582-7. PubMed ID: 23924950
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
